\u5965\u5e0c\u66ff\u5c3c80\u6beb\u514b\u7247 – \u7b80\u4ecb \u5965\u5e0c\u66ff\u5c3c80\u6beb\u514b\u7247\u662f\u6cbb\u7597\u8868\u76ae\u751f\u957f\u56e0\u5b50\u53d7\u4f53\uff08EGFR\uff09\u57fa\u56e0\u53d1\u751f\u7279\u5b9a\u6539\u53d8\u7684\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\uff08NSCLC\uff09\u7684\u4e00\u7ebf\u836f\u7269\u3002\u8fd9\u4e9b\u6539\u53d8\u88ab\u79f0\u4e3a19\u53f7\u5916\u663e\u5b50\u7f3a\u5931\u621621\u53f7\u5916\u663e\u5b50L858R\u7a81\u53d8\uff0c\u53ef\u901a\u8fc7FDA\u6279\u51c6\u7684\u68c0\u6d4b\u65b9\u6cd5\u53d1\u73b0\u3002\u5b83\u4e5f\u7528\u4e8e\u6cbb\u7597\u643a\u5e26EGFR T790M\u7a81\u53d8\u7684\u80ba\u764c\u60a3\u8005\uff0c\u5c24\u5176\u9002\u7528\u4e8e\u5728\u63a5\u53d7\u5176\u4ed6\u9776\u5411EGFR\u7684\u6cbb\u7597\u540e\u75c5\u60c5\u6076\u5316\u7684\u60a3\u8005\u3002\u5965\u5e0c\u66ff\u5c3c80\u6beb\u514b\u7247\u7531Incepta Pharmaceuticals\u516c\u53f8\u751f\u4ea7\u3002\u5b83\u542b\u6709\u5965\u5e0c\u66ff\u5c3c\uff0c\u53ef\u6291\u5236\u4e00\u79cd\u540d\u4e3aEGFR\u7684\u86cb\u767d\u8d28\uff0c\u8be5\u86cb\u767d\u8d28\u6709\u52a9\u4e8e\u764c\u7ec6\u80de\u751f\u957f\u3002\u5965\u5e0c\u66ff\u5c3c\u4e0e\u67d0\u4e9b\u7a81\u53d8\u5f62\u5f0f\u7684EGFR\u86cb\u767d\u7684\u7ed3\u5408\u529b\u8fdc\u5f3a\u4e8e\u6b63\u5e38\u5f62\u5f0f\u7684EGFR\u86cb\u767d\uff0c\u4ece\u800c\u6291\u5236\u764c\u7ec6\u80de\u7684\u751f\u957f\u3002\u5b9e\u9a8c\u5ba4\u7814\u7a76\u548c\u52a8\u7269\u6a21\u578b\u5747\u8868\u660e\uff0c\u5965\u5e0c\u66ff\u5c3c\u5bf9\u643a\u5e26\u8fd9\u4e9b\u7a81\u53d8\u7684\u80ba\u764c\u7ec6\u80de\u5177\u6709\u6700\u4f73\u7597\u6548\u3002\u9002\u5e94\u75c7\uff1a\u5965\u5e0c\u66ff\u5c3c\u662f\u4e00\u79cd\u7528\u4e8e\u6cbb\u7597\u643a\u5e26\u7279\u5b9aEGFR T790M\u7a81\u53d8\u7684\u80ba\u764c\uff08\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\uff09\u7684\u836f\u7269\u3002\u5b83\u9002\u7528\u4e8e\u764c\u75c7\u5df2\u6269\u6563\uff08\u8f6c\u79fb\uff09\u4e14\u5728\u4f7f\u7528\u5176\u4ed6EGFR\u9776\u5411\u6cbb\u7597\u540e\u75c5\u60c5\u6076\u5316\u7684\u60a3\u8005\u3002\u8be5\u7a81\u53d8\u5fc5\u987b\u901a\u8fc7FDA\u6279\u51c6\u7684\u68c0\u6d4b\u65b9\u6cd5\u8fdb\u884c\u786e\u8ba4\u3002\u5965\u5e0c\u66ff\u5c3c\u7247\uff08Osicent\uff09\u7684\u7528\u9014\uff1a\u5965\u5e0c\u66ff\u5c3c\uff08Osicent\uff0980\u6beb\u514b\u7247\u5242\u4e3b\u8981\u7528\u4e8e\u6cbb\u7597\u67d0\u4e9b\u7c7b\u578b\u7684\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\uff08NSCLC\uff09\u3002\u5177\u4f53\u800c\u8a00\uff0c\u5176\u9002\u5e94\u75c7\u5305\u62ec\uff1a\u4e00\u7ebf\u6cbb\u7597\uff1a\u9002\u7528\u4e8e\u643a\u5e26\u7279\u5b9aEGFR\u57fa\u56e0\u7a81\u53d8\uff08\u4f8b\u598219\u53f7\u5916\u663e\u5b50\u7f3a\u5931\u621621\u53f7\u5916\u663e\u5b50L858R\u7a81\u53d8\uff09\u7684\u665a\u671f\u6216\u8f6c\u79fb\u6027NSCLC\u60a3\u8005\u3002\u8fd9\u4e9b\u7a81\u53d8\u901a\u8fc7FDA\u6279\u51c6\u7684\u68c0\u6d4b\u65b9\u6cd5\u8fdb\u884c\u68c0\u6d4b\u3002\u75be\u75c5\u8fdb\u5c55\u540e\u6cbb\u7597\uff1a\u9002\u7528\u4e8e\u643a\u5e26EGFR T790M\u7a81\u53d8\u7684\u8f6c\u79fb\u6027NSCLC\u60a3\u8005\uff0c\u5c24\u5176\u662f\u5728\u63a5\u53d7\u5176\u4ed6EGFR\u9776\u5411\u6cbb\u7597\u540e\u75c5\u60c5\u6076\u5316\u7684\u60a3\u8005\u3002\u5965\u5e0c\u66ff\u5c3c\u662f\u4e00\u79cd\u963b\u65adEGFR\u86cb\u767d\u7684\u836f\u7269\uff0cEGFR\u86cb\u767d\u80fd\u591f\u4fc3\u8fdb\u67d0\u4e9b\u764c\u7ec6\u80de\u7684\u751f\u957f\u3002\u5965\u5e0c\u66ff\u5c3c\u7684\u4f5c\u7528\u673a\u5236\u662f\uff0c\u5b83\u80fd\u4e0e\u7279\u5b9a\u7684EGFR\u7a81\u53d8\u4f53\uff08\u4f8b\u5982T790M\u3001L858R\u548c19\u53f7\u5916\u663e\u5b50\u7f3a\u5931\uff09\u7d27\u5bc6\u7ed3\u5408\uff0c\u5176\u7ed3\u5408\u529b\u8fdc\u5f3a\u4e8e\u4e0e\u6b63\u5e38EGFR\u86cb\u767d\u7684\u7ed3\u5408\u529b\u3002\u5b9e\u9a8c\u5ba4\u57f9\u517b\u7ec6\u80de\u548c\u52a8\u7269\u7814\u7a76\u8868\u660e\uff0c\u5965\u5e0c\u66ff\u5c3c\u53ef\u4ee5\u6291\u5236\u643a\u5e26\u8fd9\u4e9b\u7a81\u53d8\u7684\u80ba\u764c\u7ec6\u80de\u7684\u751f\u957f\u3002\u53e3\u670d\u5965\u5e0c\u66ff\u5c3c\u540e\uff0c\u836f\u7269\u4f1a\u5728\u4f53\u5185\u4ee3\u8c22\uff0c\u8840\u6db2\u4e2d\u4e5f\u4f1a\u68c0\u6d4b\u5230\u4e24\u79cd\u76f8\u5173\u7269\u8d28\uff08AZ7550\u548cAZ5104\uff09\u3002AZ7550\u7684\u4f5c\u7528\u673a\u5236\u4e0e\u5965\u5e0c\u66ff\u5c3c\u7c7b\u4f3c\uff0c\u800cAZ5104\u5bf9\u67d0\u4e9bEGFR\u7a81\u53d8\u4f53\u548c\u6b63\u5e38EGFR\u86cb\u767d\u7684\u6291\u5236\u4f5c\u7528\u66f4\u5f3a\u3002\u6b64\u5916\uff0c\u5965\u5e0c\u66ff\u5c3c\u8fd8\u80fd\u963b\u65ad\u5176\u4ed6\u4e00\u4e9b\u5bf9\u7ec6\u80de\u751f\u957f\u81f3\u5173\u91cd\u8981\u7684\u86cb\u767d\uff0c\u4f8b\u5982HER2\u3001HER3\u3001HER4\u3001ACK1\u548cBLK\u3002\u670d\u7528\u5965\u5e0c\u66ff\u5c3c\u540e\uff0c\u8840\u836f\u6d53\u5ea6\u4f1a\u968f\u7740\u5242\u91cf\u7684\u589e\u52a0\u800c\u7a33\u6b65\u5347\u9ad8\u3002\u6bcf\u65e5\u670d\u7528\u65f6\uff0c\u836f\u7269\u4f1a\u5728\u4f53\u5185\u9010\u6e10\u79ef\u7d2f\uff0c\u7ea615\u5929\u540e\u8fbe\u5230\u7a33\u5b9a\u6c34\u5e73\u3002\u6b64\u65f6\uff0c\u8840\u836f\u6d53\u5ea6\u6700\u9ad8\u503c\u7ea6\u4e3a\u6700\u4f4e\u503c\u76841.6\u500d\u3002\u5438\u6536\uff1a\u670d\u7528\u5965\u5e0c\u66ff\u5c3c\u540e\uff0c\u7ea66\u5c0f\u65f6\u8840\u836f\u6d53\u5ea6\u8fbe\u5230\u5cf0\u503c\u3002\u5206\u5e03\uff1a\u836f\u7269\u5728\u4f53\u5185\u5206\u5e03\u5747\u5300\uff0c95%\u7684\u836f\u7269\u4e0e\u8840\u6db2\u4e2d\u7684\u86cb\u767d\u8d28\u7ed3\u5408\u3002\u6d88\u9664\uff1a\u836f\u7269\u5728\u4f53\u5185\u505c\u7559\u7ea648\u5c0f\u65f6\u540e\u88ab\u6e05\u9664\u3002\u6392\u6cc4\uff1a\u5965\u5e0c\u66ff\u5c3c\u4e3b\u8981\u7ecf\u7caa\u4fbf\u6392\u51fa\uff0868%\uff09\uff0c\u5c11\u91cf\u7ecf\u5c3f\u6db2\u6392\u51fa\uff0814%\uff09\u3002\u4ec5\u7ea62%\u4ee5\u539f\u5f62\u6392\u51fa\u4f53\u5916\u3002\u5965\u5e0c\u66ff\u5c3c\u7684\u5242\u91cf\u548c\u7528\u6cd5\uff1a\u6bcf\u65e5\u670d\u7528\u4e00\u724780\u6beb\u514b\u5965\u5e0c\u66ff\u5c3c\u7247\uff0c\u76f4\u81f3\u75c5\u60c5\u6076\u5316\u6216\u526f\u4f5c\u7528\u8fc7\u4e8e\u4e25\u91cd\u3002\u53ef\u7a7a\u8179\u6216\u968f\u9910\u670d\u7528\u3002\u5982\u679c\u6f0f\u670d\u4e00\u6b21\uff0c\u8bf7\u8df3\u8fc7\u6b64\u6b21\u5242\u91cf\uff0c\u5e76\u5728\u4e0b\u6b21\u6b63\u5e38\u65f6\u95f4\u670d\u7528\u3002\u7528\u6c34\u9001\u670d\uff1a\u5c06\u836f\u7247\u653e\u5165 60 \u6beb\u5347\uff082 \u76ce\u53f8\uff09\u4e0d\u542b\u78b3\u9178\u7684\u6c34\u4e2d\u3002\u6405\u62cc\u81f3\u836f\u7247\u788e\u88c2\u6210\u5c0f\u5757\uff08\u4e0d\u4f1a\u5b8c\u5168\u6eb6\u89e3\uff09\u3002\u7acb\u5373\u996e\u7528\u6df7\u5408\u6db2\u3002\u7528 120 \u81f3 240 \u6beb\u5347\uff084 \u81f3 8 \u76ce\u53f8\uff09\u6c34\u51b2\u6d17\u5bb9\u5668\uff0c\u5e76\u7acb\u5373\u996e\u7528\u3002\u5207\u52ff\u538b\u788e\u3001\u52a0\u70ed\u6216\u4f7f\u7528\u8d85\u58f0\u6ce2\u5904\u7406\u836f\u7247\u3002\u5982\u679c\u9700\u8981\u901a\u8fc7\u9f3b\u80c3\u7ba1\u7ed9\u836f\uff0c\u8bf7\u5c06\u836f\u7247\u5206\u6563\u5728 15 \u6beb\u5347\u4e0d\u542b\u78b3\u9178\u7684\u6c34\u4e2d\u3002\u518d\u7528 15 \u6beb\u5347\u6c34\u5c06\u5269\u4f59\u7684\u836f\u7247\u788e\u5757\u8f6c\u79fb\u5230\u6ce8\u5c04\u5668\u4e2d\u3002\u901a\u8fc7\u9f3b\u80c3\u7ba1\u6ce8\u5165 30 \u6beb\u5347\u6db2\u4f53\uff0c\u5e76\u7528\u5c11\u91cf\u6c34\u51b2\u6d17\uff08\u7ea6 30 \u6beb\u5347\uff09\u3002\u836f\u7269\u76f8\u4e92\u4f5c\u7528 \u5f3a\u6548CYP3A\u6291\u5236\u5242\uff1a\u907f\u514d\u5c06\u5965\u5e0c\u66ff\u5c3c\u4e0e\u5f3a\u6548CYP3A\u6291\u5236\u5242\uff08\u4f8b\u5982\u67d0\u4e9b\u6297\u751f\u7d20\uff08\u5982\u6cf0\u5229\u9709\u7d20\uff09\u3001\u6297\u771f\u83cc\u836f\uff08\u5982\u4f0a\u66f2\u5eb7\u5511\uff09\u548c\u6297\u75c5\u6bd2\u836f\uff08\u5982\u5229\u6258\u90a3\u97e6\uff09\uff09\u5408\u7528\uff0c\u56e0\u4e3a\u8fd9\u4e9b\u836f\u7269\u4f1a\u589e\u52a0\u8840\u6db2\u4e2d\u5965\u5e0c\u66ff\u5c3c\u7684\u6d53\u5ea6\u3002\u5982\u679c\u5fc5\u987b\u5408\u7528\u8fd9\u4e9b\u836f\u7269\uff0c\u5e94\u5bc6\u5207\u76d1\u6d4b\u60a3\u8005\u7684\u526f\u4f5c\u7528\u3002\u5f3a\u6548CYP3A\u8bf1\u5bfc\u5242\uff1a\u907f\u514d\u5c06\u5965\u5e0c\u66ff\u5c3c\u4e0e\u5f3a\u6548CYP3A\u8bf1\u5bfc\u5242\uff08\u5982\u82ef\u59a5\u82f1\u94a0\u3001\u5229\u798f\u5e73\u3001\u5361\u9a6c\u897f\u5e73\u6216\u5723\u7ea6\u7ff0\u8349\uff09\u5408\u7528\uff0c\u56e0\u4e3a\u8fd9\u4e9b\u836f\u7269\u4f1a\u964d\u4f4e\u8840\u6db2\u4e2d\u5965\u5e0c\u66ff\u5c3c\u7684\u6d53\u5ea6\u3002\u5965\u5e0c\u66ff\u5c3c80mg\u7684\u526f\u4f5c\u7528 \u6700\u5e38\u89c1\u7684\u526f\u4f5c\u7528\u5305\u62ec\uff1a\u8179\u6cfb\u3001\u76ae\u75b9\u3001\u76ae\u80a4\u5e72\u71e5\u3001\u6307\u7532\u6bd2\u6027\u3001\u53e3\u8154\u708e\u3001\u75b2\u52b3\u3001\u98df\u6b32\u4e0b\u964d\u3002\u5965\u5e0c\u66ff\u5c3c\uff08Osicent\uff09\u2014\u2014\u6ce8\u610f\u4e8b\u9879\u548c\u8b66\u544a\uff1a\u5b55\u671f\u670d\u7528\u5965\u5e0c\u66ff\u5c3c80\u6beb\u514b\u53ef\u80fd\u5bf9\u80ce\u513f\u9020\u6210\u4f24\u5bb3\u3002\u670d\u7528\u5965\u5e0c\u66ff\u5c3c\u7684\u60a3\u8005\u4e2d\uff0c3.9%\u53d1\u751f\u95f4\u8d28\u6027\u80ba\u75c5\uff08ILD\uff09\u6216\u80ba\u708e\uff1b\u5176\u4e2d0.4%\u7684\u75c5\u4f8b\u6b7b\u4ea1\u3002\u5982\u679c\u60a3\u8005\u88ab\u8bca\u65ad\u4e3aILD\u6216\u80ba\u708e\uff0c\u5e94\u6c38\u4e45\u505c\u7528\u5965\u5e0c\u66ff\u5c3c\u3002\u5965\u5e0c\u66ff\u5c3c\u53ef\u5f15\u8d77QTc\u95f4\u671f\u5ef6\u957f\uff0c\u5f71\u54cd\u5fc3\u5f8b\u3002\u6709QTc\u95f4\u671f\u5ef6\u957f\u75c5\u53f2\u7684\u60a3\u8005\u6216\u6b63\u5728\u670d\u7528\u5f71\u54cdQTc\u95f4\u671f\u836f\u7269\u7684\u60a3\u8005\u5e94\u5b9a\u671f\u8fdb\u884c\u5fc3\u7535\u56fe\u548c\u7535\u89e3\u8d28\u68c0\u67e5\u3002\u5982\u679c\u51fa\u73b0QTc\u95f4\u671f\u5ef6\u957f\uff0c\u5e94\u51cf\u5c11\u5242\u91cf\u6216\u6c38\u4e45\u505c\u836f\u3002 Osicent 80mg \u4e0e Tagrix 80mg \u5bf9\u6bd4 \u7279\u70b9 Osicent Tagrix \u6d3b\u6027\u6210\u5206 \u5965\u5e0c\u66ff\u5c3c \u5965\u5e0c\u66ff\u5c3c \u54c1\u724c\u540d\u79f0 Osicent Tagrix \u751f\u4ea7\u5546 Incepta Pharmaceuticals Ltd. Beacon Pharmaceuticals Ltd. \u836f\u7269\u7c7b\u522b EGFR \u916a\u6c28\u9178\u6fc0\u9176\u6291\u5236\u5242 EGFR \u916a\u6c28\u9178\u6fc0\u9176\u6291\u5236\u5242 \u9002\u5e94\u75c7 \u5177\u6709\u7279\u5b9a EGFR \u7a81\u53d8\u7684\u975e\u5c0f\u7ec6\u80de\u80ba\u764c (NSCLC) \u5177\u6709\u7279\u5b9a EGFR \u7a81\u53d8\u7684\u975e\u5c0f\u7ec6\u80de\u80ba\u764c (NSCLC) \u4ef7\u683c \u901a\u5e38\u66f4\u5b9e\u60e0\uff0c\u5177\u4f53\u53d6\u51b3\u4e8e\u5e02\u573a\u60c5\u51b5 \u901a\u5e38\u4e0e Osicent \u4ef7\u683c\u76f8\u4f3c\uff0c\u4f46\u56e0\u5730\u533a\u800c\u5f02 \u72ec\u7279\u4e4b\u5904 \u7531\u5b5f\u52a0\u62c9\u56fd\u77e5\u540d\u5236\u836f\u516c\u53f8 Incepta \u751f\u4ea7 \u7531\u5b5f\u52a0\u62c9\u56fd\u53e6\u4e00\u5bb6\u9886\u5148\u5236\u836f\u516c\u53f8 Beacon \u751f\u4ea7 \u5e38\u89c1\u836f\u7269\u76f8\u4e92\u4f5c\u7528 \u4e0e CYP3A4 \u6291\u5236\u5242\u3001\u6297\u9178\u5242\u548c\u8d28\u5b50\u6cf5\u6291\u5236\u5242\u76f8\u4e92\u4f5c\u7528 \u4e0e CYP3A4 \u6291\u5236\u5242\u3001\u6297\u9178\u5242\u548c\u8d28\u5b50\u6cf5\u6291\u5236\u5242\u76f8\u4e92\u4f5c\u7528 FDA \u6279\u51c6 \u5965\u5e0c\u66ff\u5c3c\u662f\u4e00\u79cdFDA \u6279\u51c6\u7684\u836f\u7269\u5965\u5e0c\u66ff\u5c3c\u662f\u4e00\u79cd FDA \u6279\u51c6\u7684\u836f\u7269\u3002\u50a8\u5b58\u6761\u4ef6\uff1a\u4fdd\u6301\u5728 30\u00b0C \u4ee5\u4e0b\uff0c\u5e76\u907f\u5149\u9632\u6f6e\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"
\u5965\u5e0c\u66ff\u5c3c80\u6beb\u514b\u7247 – \u7b80\u4ecb \u5965\u5e0c\u66ff\u5c3c80\u6beb\u514b\u7247\u662f\u6cbb\u7597\u8868\u76ae\u751f\u957f\u56e0\u5b50\u53d7\u4f53\uff08EGFR\uff09\u57fa\u56e0\u53d1\u751f\u7279\u5b9a\u6539\u53d8\u7684\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\uff08NSCLC\uff09\u7684\u4e00\u7ebf\u836f\u7269\u3002\u8fd9\u4e9b\u6539\u53d8\u88ab\u79f0\u4e3a19\u53f7\u5916\u663e\u5b50\u7f3a\u5931\u621621\u53f7\u5916\u663e\u5b50L858R\u7a81\u53d8\uff0c\u53ef\u901a\u8fc7FDA\u6279\u51c6\u7684\u68c0\u6d4b\u65b9\u6cd5\u53d1\u73b0\u3002\u5b83\u4e5f\u7528\u4e8e\u6cbb\u7597\u643a\u5e26EGFR T790M\u7a81\u53d8\u7684\u80ba\u764c\u60a3\u8005\uff0c\u5c24\u5176\u9002\u7528\u4e8e\u5728\u63a5\u53d7\u5176\u4ed6\u9776\u5411EGFR\u7684\u6cbb\u7597\u540e\u75c5\u60c5\u6076\u5316\u7684\u60a3\u8005\u3002\u5965\u5e0c\u66ff\u5c3c80\u6beb\u514b\u7247\u7531Incepta Pharmaceuticals\u516c\u53f8\u751f\u4ea7\u3002\u5b83\u542b\u6709\u5965\u5e0c\u66ff\u5c3c\uff0c\u53ef\u6291\u5236\u4e00\u79cd\u540d\u4e3aEGFR\u7684\u86cb\u767d\u8d28\uff0c\u8be5\u86cb\u767d\u8d28\u6709\u52a9\u4e8e\u764c\u7ec6\u80de\u751f\u957f\u3002\u5965\u5e0c\u66ff\u5c3c\u4e0e\u67d0\u4e9b\u7a81\u53d8\u5f62\u5f0f\u7684EGFR\u86cb\u767d\u7684\u7ed3\u5408\u529b\u8fdc\u5f3a\u4e8e\u6b63\u5e38\u5f62\u5f0f\u7684EGFR\u86cb\u767d\uff0c\u4ece\u800c\u6291\u5236\u764c\u7ec6\u80de\u7684\u751f\u957f\u3002\u5b9e\u9a8c\u5ba4\u7814\u7a76\u548c\u52a8\u7269\u6a21\u578b\u5747\u8868\u660e\uff0c\u5965\u5e0c\u66ff\u5c3c\u5bf9\u643a\u5e26\u8fd9\u4e9b\u7a81\u53d8\u7684\u80ba\u764c\u7ec6\u80de\u5177\u6709\u6700\u4f73\u7597\u6548\u3002\u9002\u5e94\u75c7\uff1a\u5965\u5e0c\u66ff\u5c3c\u662f\u4e00\u79cd\u7528\u4e8e\u6cbb\u7597\u643a\u5e26\u7279\u5b9aEGFR T790M\u7a81\u53d8\u7684\u80ba\u764c\uff08\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\uff09\u7684\u836f\u7269\u3002\u5b83\u9002\u7528\u4e8e\u764c\u75c7\u5df2\u6269\u6563\uff08\u8f6c\u79fb\uff09\u4e14\u5728\u4f7f\u7528\u5176\u4ed6EGFR\u9776\u5411\u6cbb\u7597\u540e\u75c5\u60c5\u6076\u5316\u7684\u60a3\u8005\u3002\u8be5\u7a81\u53d8\u5fc5\u987b\u901a\u8fc7FDA\u6279\u51c6\u7684\u68c0\u6d4b\u65b9\u6cd5\u8fdb\u884c\u786e\u8ba4\u3002\u5965\u5e0c\u66ff\u5c3c\u7247\uff08Osicent\uff09\u7684\u7528\u9014\uff1a\u5965\u5e0c\u66ff\u5c3c\uff08Osicent\uff0980\u6beb\u514b\u7247\u5242\u4e3b\u8981\u7528\u4e8e\u6cbb\u7597\u67d0\u4e9b\u7c7b\u578b\u7684\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\uff08NSCLC\uff09\u3002\u5177\u4f53\u800c\u8a00\uff0c\u5176\u9002\u5e94\u75c7\u5305\u62ec\uff1a\u4e00\u7ebf\u6cbb\u7597\uff1a\u9002\u7528\u4e8e\u643a\u5e26\u7279\u5b9aEGFR\u57fa\u56e0\u7a81\u53d8\uff08\u4f8b\u598219\u53f7\u5916\u663e\u5b50\u7f3a\u5931\u621621\u53f7\u5916\u663e\u5b50L858R\u7a81\u53d8\uff09\u7684\u665a\u671f\u6216\u8f6c\u79fb\u6027NSCLC\u60a3\u8005\u3002\u8fd9\u4e9b\u7a81\u53d8\u901a\u8fc7FDA\u6279\u51c6\u7684\u68c0\u6d4b\u65b9\u6cd5\u8fdb\u884c\u68c0\u6d4b\u3002\u75be\u75c5\u8fdb\u5c55\u540e\u6cbb\u7597\uff1a\u9002\u7528\u4e8e\u643a\u5e26EGFR T790M\u7a81\u53d8\u7684\u8f6c\u79fb\u6027NSCLC\u60a3\u8005\uff0c\u5c24\u5176\u662f\u5728\u63a5\u53d7\u5176\u4ed6EGFR\u9776\u5411\u6cbb\u7597\u540e\u75c5\u60c5\u6076\u5316\u7684\u60a3\u8005\u3002\u5965\u5e0c\u66ff\u5c3c\u662f\u4e00\u79cd\u963b\u65adEGFR\u86cb\u767d\u7684\u836f\u7269\uff0cEGFR\u86cb\u767d\u80fd\u591f\u4fc3\u8fdb\u67d0\u4e9b\u764c\u7ec6\u80de\u7684\u751f\u957f\u3002\u5965\u5e0c\u66ff\u5c3c\u7684\u4f5c\u7528\u673a\u5236\u662f\uff0c\u5b83\u80fd\u4e0e\u7279\u5b9a\u7684EGFR\u7a81\u53d8\u4f53\uff08\u4f8b\u5982T790M\u3001L858R\u548c19\u53f7\u5916\u663e\u5b50\u7f3a\u5931\uff09\u7d27\u5bc6\u7ed3\u5408\uff0c\u5176\u7ed3\u5408\u529b\u8fdc\u5f3a\u4e8e\u4e0e\u6b63\u5e38EGFR\u86cb\u767d\u7684\u7ed3\u5408\u529b\u3002\u5b9e\u9a8c\u5ba4\u57f9\u517b\u7ec6\u80de\u548c\u52a8\u7269\u7814\u7a76\u8868\u660e\uff0c\u5965\u5e0c\u66ff\u5c3c\u53ef\u4ee5\u6291\u5236\u643a\u5e26\u8fd9\u4e9b\u7a81\u53d8\u7684\u80ba\u764c\u7ec6\u80de\u7684\u751f\u957f\u3002\u53e3\u670d\u5965\u5e0c\u66ff\u5c3c\u540e\uff0c\u836f\u7269\u4f1a\u5728\u4f53\u5185\u4ee3\u8c22\uff0c\u8840\u6db2\u4e2d\u4e5f\u4f1a\u68c0\u6d4b\u5230\u4e24\u79cd\u76f8\u5173\u7269\u8d28\uff08AZ7550\u548cAZ5104\uff09\u3002AZ7550\u7684\u4f5c\u7528\u673a\u5236\u4e0e\u5965\u5e0c\u66ff\u5c3c\u7c7b\u4f3c\uff0c\u800cAZ5104\u5bf9\u67d0\u4e9bEGFR\u7a81\u53d8\u4f53\u548c\u6b63\u5e38EGFR\u86cb\u767d\u7684\u6291\u5236\u4f5c\u7528\u66f4\u5f3a\u3002\u6b64\u5916\uff0c\u5965\u5e0c\u66ff\u5c3c\u8fd8\u80fd\u963b\u65ad\u5176\u4ed6\u4e00\u4e9b\u5bf9\u7ec6\u80de\u751f\u957f\u81f3\u5173\u91cd\u8981\u7684\u86cb\u767d\uff0c\u4f8b\u5982HER2\u3001HER3\u3001HER4\u3001ACK1\u548cBLK\u3002\u670d\u7528\u5965\u5e0c\u66ff\u5c3c\u540e\uff0c\u8840\u836f\u6d53\u5ea6\u4f1a\u968f\u7740\u5242\u91cf\u7684\u589e\u52a0\u800c\u7a33\u6b65\u5347\u9ad8\u3002\u6bcf\u65e5\u670d\u7528\u65f6\uff0c\u836f\u7269\u4f1a\u5728\u4f53\u5185\u9010\u6e10\u79ef\u7d2f\uff0c\u7ea615\u5929\u540e\u8fbe\u5230\u7a33\u5b9a\u6c34\u5e73\u3002\u6b64\u65f6\uff0c\u8840\u836f\u6d53\u5ea6\u6700\u9ad8\u503c\u7ea6\u4e3a\u6700\u4f4e\u503c\u76841.6\u500d\u3002\u5438\u6536\uff1a\u670d\u7528\u5965\u5e0c\u66ff\u5c3c\u540e\uff0c\u7ea66\u5c0f\u65f6\u8840\u836f\u6d53\u5ea6\u8fbe\u5230\u5cf0\u503c\u3002\u5206\u5e03\uff1a\u836f\u7269\u5728\u4f53\u5185\u5206\u5e03\u5747\u5300\uff0c95%\u7684\u836f\u7269\u4e0e\u8840\u6db2\u4e2d\u7684\u86cb\u767d\u8d28\u7ed3\u5408\u3002\u6d88\u9664\uff1a\u836f\u7269\u5728\u4f53\u5185\u505c\u7559\u7ea648\u5c0f\u65f6\u540e\u88ab\u6e05\u9664\u3002\u6392\u6cc4\uff1a\u5965\u5e0c\u66ff\u5c3c\u4e3b\u8981\u7ecf\u7caa\u4fbf\u6392\u51fa\uff0868%\uff09\uff0c\u5c11\u91cf\u7ecf\u5c3f\u6db2\u6392\u51fa\uff0814%\uff09\u3002\u4ec5\u7ea62%\u4ee5\u539f\u5f62\u6392\u51fa\u4f53\u5916\u3002\u5965\u5e0c\u66ff\u5c3c\u7684\u5242\u91cf\u548c\u7528\u6cd5\uff1a\u6bcf\u65e5\u670d\u7528\u4e00\u724780\u6beb\u514b\u5965\u5e0c\u66ff\u5c3c\u7247\uff0c\u76f4\u81f3\u75c5\u60c5\u6076\u5316\u6216\u526f\u4f5c\u7528\u8fc7\u4e8e\u4e25\u91cd\u3002\u53ef\u7a7a\u8179\u6216\u968f\u9910\u670d\u7528\u3002\u5982\u679c\u6f0f\u670d\u4e00\u6b21\uff0c\u8bf7\u8df3\u8fc7\u6b64\u6b21\u5242\u91cf\uff0c\u5e76\u5728\u4e0b\u6b21\u6b63\u5e38\u65f6\u95f4\u670d\u7528\u3002\u7528\u6c34\u9001\u670d\uff1a\u5c06\u836f\u7247\u653e\u5165 60 \u6beb\u5347\uff082 \u76ce\u53f8\uff09\u4e0d\u542b\u78b3\u9178\u7684\u6c34\u4e2d\u3002\u6405\u62cc\u81f3\u836f\u7247\u788e\u88c2\u6210\u5c0f\u5757\uff08\u4e0d\u4f1a\u5b8c\u5168\u6eb6\u89e3\uff09\u3002\u7acb\u5373\u996e\u7528\u6df7\u5408\u6db2\u3002\u7528 120 \u81f3 240 \u6beb\u5347\uff084 \u81f3 8 \u76ce\u53f8\uff09\u6c34\u51b2\u6d17\u5bb9\u5668\uff0c\u5e76\u7acb\u5373\u996e\u7528\u3002\u5207\u52ff\u538b\u788e\u3001\u52a0\u70ed\u6216\u4f7f\u7528\u8d85\u58f0\u6ce2\u5904\u7406\u836f\u7247\u3002\u5982\u679c\u9700\u8981\u901a\u8fc7\u9f3b\u80c3\u7ba1\u7ed9\u836f\uff0c\u8bf7\u5c06\u836f\u7247\u5206\u6563\u5728 15 \u6beb\u5347\u4e0d\u542b\u78b3\u9178\u7684\u6c34\u4e2d\u3002\u518d\u7528<\/p>\n","protected":false},"featured_media":0,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[3216],"product_cat":[15998,15925,15926],"product_tag":[11762,22415,20756,11753],"class_list":["post-40742","product","type-product","status-publish","product_brand-incepta-pharmaceuticals","product_cat-lung-cancer","product_cat-oncology","product_cat-speciality-medicines","product_tag-bottle","product_tag-osicent","product_tag-osimertinib","product_tag-tablet","pa_brand-name-osicent","pa_molecule-osimertinib-zh-hans","first","instock","shipping-taxable","product-type-simple"],"_links":{"self":[{"href":"https:\/\/indogenmed.org\/zh-hans\/wp-json\/wp\/v2\/product\/40742","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/indogenmed.org\/zh-hans\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/indogenmed.org\/zh-hans\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/indogenmed.org\/zh-hans\/wp-json\/wp\/v2\/comments?post=40742"}],"version-history":[{"count":0,"href":"https:\/\/indogenmed.org\/zh-hans\/wp-json\/wp\/v2\/product\/40742\/revisions"}],"wp:attachment":[{"href":"https:\/\/indogenmed.org\/zh-hans\/wp-json\/wp\/v2\/media?parent=40742"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/indogenmed.org\/zh-hans\/wp-json\/wp\/v2\/product_brand?post=40742"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/indogenmed.org\/zh-hans\/wp-json\/wp\/v2\/product_cat?post=40742"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/indogenmed.org\/zh-hans\/wp-json\/wp\/v2\/product_tag?post=40742"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}